What does Spine 8 do?

Spine 8 is a commercial agency in Heist-op-den-Berg. Private Limited, started on 22 May 2019, 1 establishment.

What is the address of Spine 8?

The registered office of Spine 8 is located at Heksestraat(ITE) 88, 2222 Heist-op-den-Berg.

Is Spine 8 still active?

Yes. According to the CBE (17 September 2026) Spine 8 is active, legal situation “Normale toestand”, started on 22 May 2019.

Is Spine 8 registered on Peppol?

Yes, Spine 8 is registered on the Peppol network with ID 0208:0727374987.

What is the enterprise number of Spine 8?

The enterprise number of Spine 8 is BE0727374987.

When was Spine 8 founded?

Spine 8 was founded on 22 May 2019.

Who are the directors of Spine 8?

According to the 2025 annual accounts, the directors of Spine 8 are: VH Consult BV, Medical Investment & Consultancy BV, Flocare Bv BV, Rubcare BV.

Is Spine 8 a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 May 2019; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did Spine 8 make in 2025?

Spine 8 posted a profit after taxes of € 202,421 in financial year 2025.

What is the revenue of Spine 8?

As a small company, Spine 8 is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 706,072.

How much does an employee at Spine 8 earn?

The average wage cost per full-time employee at Spine 8 was € 129,200 in 2025: staff costs of € 413,549 for 3.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Spine 8 have?

According to the 2025 annual accounts, Spine 8 has 3.2 full-time equivalents (FTE).

Spine 8 (Private Limited) - Heist-op-den-Berg

Dossier Spine 8, printed on 17 September 2026 from databakkes.be/en/0727374987/spine-8. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Spine 8 from Heist-op-den-Berg, company number BE0727374987, closed financial year 2025 with a result of € 202,421 after tax. For that financial year Spine 8 recorded a gross margin of € 706,072 and equity of € 205,051. Compared with financial year 2024, the result moved from € 914,786 to € 202,421. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Growing

€ 205,051

▲ 44% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 202,421

▼ 78% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 144,142

▲ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 140,000 paid out

69 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

3.2

▼ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 413,549

▼ 1% vs 2024

€ 129,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 371

▼ 58% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 345,761

▲ € 316,903 vs 2024

€ 53,697 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 225,116

▼ 19% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 155,049

▲ 202% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 328,952 Gross margin 2022: € 328,952 First fiscal year in the series	€ 518,691 Gross margin 2023: € 518,691 ▲ 58% vs 2022 (€ 328,952) Favourable step	€ 1,378,509 Gross margin 2024: € 1,378,509 ▲ 166% vs 2023 (€ 518,691) Favourable step	€ 706,072 Gross margin 2025: € 706,072 ▼ 49% vs 2024 (€ 1,378,509) Unfavourable step	▼ 49%
Profit after taxes	€ 226,674 Profit after taxes 2022: € 226,674 First fiscal year in the series	€ 249,590 Profit after taxes 2023: € 249,590 ▲ 10% vs 2022 (€ 226,674) Favourable step	€ 914,786 Profit after taxes 2024: € 914,786 ▲ 267% vs 2023 (€ 249,590) Favourable step	€ 202,421 Profit after taxes 2025: € 202,421 ▼ 78% vs 2024 (€ 914,786) Unfavourable step	▼ 78%
Equity	€ 38,254 Equity 2022: € 38,254 First fiscal year in the series	€ 47,844 Equity 2023: € 47,844 ▲ 25% vs 2022 (€ 38,254) Favourable step	€ 142,630 Equity 2024: € 142,630 ▲ 198% vs 2023 (€ 47,844) Favourable step	€ 205,051 Equity 2025: € 205,051 ▲ 44% vs 2024 (€ 142,630) Favourable step	▲ 44%
Total debts	€ 309,027 Total debts 2022: € 309,027 First fiscal year in the series	€ 339,979 Total debts 2023: € 339,979 ▲ 10% vs 2022 (€ 309,027) Unfavourable step	€ 1,177,300 Total debts 2024: € 1,177,300 ▲ 246% vs 2023 (€ 339,979) Unfavourable step	€ 866,487 Total debts 2025: € 866,487 ▼ 26% vs 2024 (€ 1,177,300) Favourable step	▼ 26%
Cash	€ 128,095 Cash 2022: € 128,095 First fiscal year in the series	€ 175,077 Cash 2023: € 175,077 ▲ 37% vs 2022 (€ 128,095) Favourable step	€ 133,605 Cash 2024: € 133,605 ▼ 24% vs 2023 (€ 175,077) Unfavourable step	€ 144,142 Cash 2025: € 144,142 ▲ 8% vs 2024 (€ 133,605) Favourable step	▲ 8%
Retained profit	€ 32,054 Retained profit 2022: € 32,054 First fiscal year in the series	€ 41,644 Retained profit 2023: € 41,644 ▲ 30% vs 2022 (€ 32,054) Favourable step	€ 136,430 Retained profit 2024: € 136,430 ▲ 228% vs 2023 (€ 41,644) Favourable step	€ 198,851 Retained profit 2025: € 198,851 ▲ 46% vs 2024 (€ 136,430) Favourable step	▲ 46%
Dividend	€ 225,000 Dividend 2022: € 225,000 First fiscal year in the series	€ 240,000 Dividend 2023: € 240,000 ▲ 7% vs 2022 (€ 225,000) Unchanged	€ 820,000 Dividend 2024: € 820,000 ▲ 242% vs 2023 (€ 240,000) Unchanged	€ 140,000 Dividend 2025: € 140,000 ▼ 83% vs 2024 (€ 820,000) Unchanged	▼ 83%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 28,858 Bank debt 2024: € 28,858 Unchanged (€ 0) Unfavourable step	€ 345,761 Bank debt 2025: € 345,761 ▲ € 316,903 vs 2024 (€ 28,858) Unfavourable step	▲ € 316,903
Balance sheet total	€ 347,281 Balance sheet total 2022: € 347,281 First fiscal year in the series	€ 387,823 Balance sheet total 2023: € 387,823 ▲ 12% vs 2022 (€ 347,281) Unchanged	€ 1,319,930 Balance sheet total 2024: € 1,319,930 ▲ 240% vs 2023 (€ 387,823) Unchanged	€ 1,071,539 Balance sheet total 2025: € 1,071,539 ▼ 19% vs 2024 (€ 1,319,930) Unchanged	▼ 19%
Employees (FTE)	-	2.4 Employees (FTE) 2023: 2.4 First fiscal year in the series	3.8 Employees (FTE) 2024: 3.8 ▲ 1.4 vs 2023 (2.4) Unchanged	3.2 Employees (FTE) 2025: 3.2 ▼ 0.6 vs 2024 (3.8) Unchanged	▼ 0.6

Key figures of Spine 8, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Spine 8?

What happened at Spine 8 in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 202,421 (▼ 78% vs 2024). Source: NBB ↗
2023 Flocare Bv BV became a director. NBB
2021 Rubcare BV became a director. NBB
2020 VH Consult BV became a director. NBB
2020 Medical Investment & Consultancy BV became a director. NBB
May 22, 2019 New establishment in Heist-op-den-Berg. KBO
May 22, 2019 Start of the company according to the CBE. KBO

In short

From € 226,674 profit in 2022 to € 202,421 profit in 2025.

Paid € 79,039 in corporate taxes since 2022.

Best year ever: 2024, with € 914,786 profit.

On average € 220,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at Spine 8? We notify you, reason included.

Follow Spine 8

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Flocare 25%

RUBCARE 25%

The stake of Flocare, RUBCARE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Spine 8

Behind Spine 8 are VH Consult BV, Medical Investment & Consultancy BV, Flocare Bv BV and Rubcare BV. The shares are held by Flocare (25%) and RUBCARE (25%).

See the full network in the app